ScriptMed® Achieves Surescripts Certification for RxTransfer to Support Specialty, Infusion, and Hub Pharmacies
ScriptMed® Achieves Surescripts Certification for RxTransfer to Support Specialty, Infusion, and Hub Pharmacies
New RxTransfer function in Inovalon’s ScriptMed replaces fax-and-phone transfer workflows with electronic prescription transfers and status visibility
Inovalon, a leading provider of data and solutions empowering data-driven healthcare, today announced that its ScriptMed® pharmacy management solution has achieved Surescripts® certification for RxTransfer, a new transaction as part of the National Council for Prescription Drug Programs (NCPDP) standard. The certification enables ScriptMed to support bi-directional electronic prescription transfers for its pharmacy customers.
"RxTransfer certification advances ScriptMed in the market," said Ernie Shopes, President of Inovalon’s Pharmacy Business Unit. "As adoption accelerates industry-wide, giving pharmacies a faster, electronic way to move prescriptions, our customers spend less time chasing paperwork and more time getting patients their medication."
Moving a specialty prescription from one pharmacy to another has often meant faxing the script, calling the receiving location, and waiting for the prescriber to reauthorize. ScriptMed’s RxTransfer capability can now work in both directions, letting a pharmacy request a prescription from another location or push one directly to the pharmacy that can dispense it, with status tracking from pending through completion in place of a fax and a call log.
"Transferring a prescription is one of the last pharmacy workflows that often requires a fax and a follow-up phone call to complete," said Lawrence King, PharmD, Vice President, Product Innovation, Intelligent Prescribing at Surescripts. "By certifying ScriptMed for Surescripts RxTransfer, Inovalon gives specialty and infusion pharmacies a standards-based way to move a prescription to the location that can fill it, helping patients access needed therapies without undue delay while giving pharmacists time back.”
Becoming certified for Surescripts RxTransfer means a simplified process within the ScriptMed workflow, helping specialty, infusion, hub, and non-dispensing organizations coordinate transfers with fewer manual touchpoints while providing greater visibility from request through completion. With RxTransfer, a pharmacy processing hundreds of transfers a day can potentially save hours of staff time otherwise spent on faxes and callbacks, while also removing the burden on prescribers.
ScriptMed is Inovalon’s data-driven, end-to-end pharmacy management solution that helps specialty and infusion pharmacy operations reduce time-to-fill, lower costs, enhance patient experience, and improve outcomes. The software supports prescription intake, dispensing workflows, fulfillment, inventory management, clinical management, revenue cycle management, and general day-to-day transaction processing within secure, compliant environments.
To learn more about ScriptMed and Inovalon’s pharmacy management solutions, please visit: https://www.inovalon.com/products/pharmacy-cloud/
About Inovalon
Inovalon is a leading provider of data and solutions empowering data-driven healthcare. We bring together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by over 50,000 active, licensed customers, and are informed by the primary source data of more than 99 billion medical, pharmacy, and lab events across 1.1 million clinicians, 736,000 clinical settings, and 461 million unique lives. For more information, visit www.inovalon.com.
Tom Paolella
AVP, Press and Analyst Relations, Inovalon
Thomas.Paolella@inovalon.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260903640021/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
Are TIPS ETFs the Best Way to Fight Inflation?
What’s Ahead for Stocks This Quarter—and Where to Invest
10 Best Blue-Chip Stocks to Buy for the Long Term